Anthropic’s rapid revenue expansion and upcoming IPO preparations anchor trader sentiment, with the $1.75–2.00T and $2.00–2.25T bands holding the highest implied probabilities. The company’s annualized run rate climbed from roughly $9 billion at the end of 2025 to $65 billion by late July 2026, supported by Claude model releases and enterprise adoption that recently edged ahead of OpenAI in some business metrics. Investors are pricing in aggressive 2028 revenue forecasts near $190–200 billion and a potential $2 trillion valuation as the firm prepares to file its prospectus in late September and begin marketing in mid-October. Competitive pressure from OpenAI’s latest models and Google’s Gemini adds uncertainty over sustained leadership and achievable multiples, keeping the two leading valuation ranges closely contested.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado$1.75–$2.00T 42%
$2.00–$2.25T 33.7%
$1.50–$1.75T 11.3%
$2.25–$2.50T 2.7%
$39,252 Vol.
$39,252 Vol.
31 dic 2027
<$1.25T
<1%
$1.25–$1.50T
1%
$1.50–$1.75T
11%
$1.75–$2.00T
42%
$2.00–$2.25T
34%
$2.25–$2.50T
3%
$2.50T+
1%
No IPO by December 31, 2027
<1%
$1.75–$2.00T 42%
$2.00–$2.25T 33.7%
$1.50–$1.75T 11.3%
$2.25–$2.50T 2.7%
$39,252 Vol.
$39,252 Vol.
31 dic 2027
<$1.25T
$1,158 Vol.
<1%
$1.25–$1.50T
$1,610 Vol.
1%
$1.50–$1.75T
$6,419 Vol.
11%
$1.75–$2.00T
$16,064 Vol.
42%
$2.00–$2.25T
$9,466 Vol.
34%
$2.25–$2.50T
$1,659 Vol.
3%
$2.50T+
$1,528 Vol.
1%
No IPO by December 31, 2027
$1,348 Vol.
<1%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion and upcoming IPO preparations anchor trader sentiment, with the $1.75–2.00T and $2.00–2.25T bands holding the highest implied probabilities. The company’s annualized run rate climbed from roughly $9 billion at the end of 2025 to $65 billion by late July 2026, supported by Claude model releases and enterprise adoption that recently edged ahead of OpenAI in some business metrics. Investors are pricing in aggressive 2028 revenue forecasts near $190–200 billion and a potential $2 trillion valuation as the firm prepares to file its prospectus in late September and begin marketing in mid-October. Competitive pressure from OpenAI’s latest models and Google’s Gemini adds uncertainty over sustained leadership and achievable multiples, keeping the two leading valuation ranges closely contested.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Mercado abierto: Aug 19, 2026, 9:45 AM ET
Volumen
$39,252Fecha de finalización
1 ene 2028Mercado abierto
Aug 19, 2026, 9:45 AM ETResolver
0x69c47De9D...This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Anthropic’s rapid revenue expansion and upcoming IPO preparations anchor trader sentiment, with the $1.75–2.00T and $2.00–2.25T bands holding the highest implied probabilities. The company’s annualized run rate climbed from roughly $9 billion at the end of 2025 to $65 billion by late July 2026, supported by Claude model releases and enterprise adoption that recently edged ahead of OpenAI in some business metrics. Investors are pricing in aggressive 2028 revenue forecasts near $190–200 billion and a potential $2 trillion valuation as the firm prepares to file its prospectus in late September and begin marketing in mid-October. Competitive pressure from OpenAI’s latest models and Google’s Gemini adds uncertainty over sustained leadership and achievable multiples, keeping the two leading valuation ranges closely contested.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Volumen
$39,252Fecha de finalización
1 ene 2028Mercado abierto
Aug 19, 2026, 9:45 AM ETResolver
0x69c47De9D...Anthropic’s rapid revenue expansion and upcoming IPO preparations anchor trader sentiment, with the $1.75–2.00T and $2.00–2.25T bands holding the highest implied probabilities. The company’s annualized run rate climbed from roughly $9 billion at the end of 2025 to $65 billion by late July 2026, supported by Claude model releases and enterprise adoption that recently edged ahead of OpenAI in some business metrics. Investors are pricing in aggressive 2028 revenue forecasts near $190–200 billion and a potential $2 trillion valuation as the firm prepares to file its prospectus in late September and begin marketing in mid-October. Competitive pressure from OpenAI’s latest models and Google’s Gemini adds uncertainty over sustained leadership and achievable multiples, keeping the two leading valuation ranges closely contested.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoRelacionado
Will Anthropic's market cap be between $2.0T and $2.25T at market close on IPO day?
22%
¿La capitalización de mercado de Anthropic será de 600.000 millones de dólares o más al cierre del mercado en el día de su salida a bolsa antes del 31 de diciembre de 2027?
96%
Sí
Will Anthropic’s market cap be 1.8T or greater at market close on IPO day by December 31 2027?
86%
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes